This guidance is intended for policymakers responsible for the planning and delivery of healthcare services in the national or sub-national custodial system and all professionals responsible for the health and well-being of people in prison, including community-based service providers and those facilitating continuity of care in the community.
The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe took place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants were epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting was by invitation only.
This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.
In their joint public health Guidance published today, ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), present the evidence on active case finding as a key measure to diagnose communicable diseases early.
After the EPIS FWD notification of a cluster of hepatitis A cases infected with two distinct strains in several EU/EEA countries, this risk assessment presents the early findings of this multi-country hepatitis A outbreak and sets out initial options for response.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25 February-3 March 2018 and includes updates on hepatitis A, influenza A(H7N9), seasonal influenza, MERS-CoV, mass gathering monitoring, poliomyelitis, yellow fever, and deaths linked to cold weather.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 February 2018 and includes updates on poliomyelitis, hepatitis A, seasonal influenza, rubella, measles, meningitis, mass gathering monitoring (Olympics) and yellow fever.